ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

By sjmartinez • October 31, 2024

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak SU, Paredes R, Parmar M, Peltan ID, Proschan M, Shotwell MS, Vock DM, Yokum T, Adam SJ. ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic. J Clin Transl Sci. 2024 Oct 15;8(1):e151. doi: 10.1017/cts.2024.1. PMID: 39478775; PMCID: PMC11523015.

Tags: ACTIV, Clinical Trial, covid-19, design, Infectious Diseases, lessons, Publications

Opioid agonist therapy adherence trajectories among commercially and publicly insured people living with Hepatitis C in the United States

Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ. Opioid agonist therapy adherence trajectories among commercially and publicly insured people[...]

Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent Traveler in Belize and Guatemala

Ko MY, Fowler E, Scott A, Uslan DZ. Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent[...]

Libraries Burned, a Life Lived

Vijayan T. Libraries Burned, a Life Lived. N Engl J Med. 2025 Jul 5. doi: 10.1056/NEJMp2500746. Epub ahead of print. PMID: 40621845.